Clinical Trial Detail

NCT ID NCT01925573
Title NOVOTTF-100A+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Maryland
Indications

glioblastoma multiforme

malignant glioma

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.